Sponsor content
296 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Hydrocortisone-AFT hydrocortisone (as sodium succinate) 100 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GLYCOPYRRONIUM-AFT glycopyrronium bromide (glycopyrrolate) 200 microgram/1 mL injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT Pharmaceuticals Pty Ltd - Eye heat therapy pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Parecoxib-AFT parecoxib (as sodium) 40 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FULVESTRANT-AFT fulvestrant 250 mg/5 mL solution for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: plerixafor.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARSENIC TRIOXIDE-AFT arsenic trioxide 12 mg/12 mL concentrated solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHADONE-AFT methadone hydrochloride 10 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METHADONE-AFT methadone hydrochloride 5 mg tablet blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024